StockTipsArenaBeta

BUY Anthem Biosciences Limited — Ashish Bahety, Profitmart Securities

BUYAnthem Biosciences Limited
Anthem Biosciences share price target & all analyst calls

byAshish Bahety, Profitmart SecuritiesHorizon: NA (inferred Swing (≤2wk))2 Sept 2026via CNBC Awaaz.

Entry₹938.05Inferred
Target₹990
Total upside +5.54% (call closed)
Stop loss₹910-2.99% risk
Exit₹91016 Sept 2026, 1:00 pm
Stop-loss hit-2.99%
Follow Ashish Bahety for new calls(34% target hit, 235 closed calls)Get alertsWatch ANTHEM for new buy/sell callsGet alertsSee 148 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 16 Sept 2026
2 supporting3 neutral0 opposing
Supports the BUY call (2)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·2 Sept · 2w ago

Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 target

NewsEt-Markets·21 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (3)

Anthem Biosciences, Shivalik Bimetal: బ్రోకరేజ్ సంస్థల రేడార్‌లోకి కొత్త స్టాక్స్!

NewsGoogle News·27 Aug · 3w ago

(opens in new tab)

Anthem Biosciences, Shivalik Bimetal Garner Brokerage Attention

NewsGoogle News·27 Aug · 3w ago

(opens in new tab)

JSW Steel, Anthem Biosciences ਅਤੇ eClerx: ਟੈਕਨੀਕਲ ਐਨਾਲਿਸਟ ਨੇ ਦਿੱਤੇ ਵੱਡੇ ਸੰਕੇਤ, ਜਾਣੋ ਕਿਹੜੇ ਲੈਵਲ 'ਤੇ ਰੱਖੀਏ ਨਜ਼ਰ

NewsGoogle News·27 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anthem Biosciences

All analyst calls on Anthem Biosciences

More from Ashish Bahety, Profitmart Securities

Every call and its outcome